Track and Trace Solutions Market worth $14.73 billion by 2031
This growth has been fueled by the FDA granting an interim period from November 2023 until November 2024 for facilitating the deployment and verification of electronic interoperable tracking systems by trading partners, stressing the magnitude of organizational transformation that is needed along the pharmaceutical supply chain. The ECodesign for Sustainable Products Regulation, passed into law in July 2024 by the EU, which established the framework for Digital Product Passports for physical products, represents another long-term driving factor toward product-level data collection and traceability in European supply chains. The rising prevalence of 2D barcodes, Data Matrix codes, radio frequency identification technology, near field communication technology, cloud-based traceability systems, and information sharing using EPCIS data is also fostering market growth. On the contrary, high installation expenses, interoperability with outdated packaging lines, poor data quality, and differing country-by-country compliance policies are impeding adoption rates among smaller manufacturers.
Based on application, the track and trace solutions market is segmented into serialization, aggregation, warehouse & distribution traceability, compliance & reporting, and authentication & brand protection. Among these, authentication & brand protection applications are expected to exhibit the fastest growth during the forecast period, owing to rising concerns regarding the issues of counterfeit products, product diversion, parallel trading, and misuse of brands associated with products such as pharmaceuticals, food, cosmetics, and consumer goods. Nowadays, firms use several product authentication technologies, such as QR code, Data Matrix code, RFID, NFC, and other such digital methods, to verify the authenticity of their products at various points in the supply chain. For instance, the use of such technology in pharmaceuticals would ensure patient safety by limiting the spread of fake drugs in the market. Meanwhile, in cosmetics and food items, it helps brands develop trust among consumers. Thus, with increasing significance among manufacturers, this segment will likely be most active in the market.
Based on deployment model, the track and trace solutions market is segmented into on-premises, cloud-based, and hybrid solutions. In 2025, the cloud-based segment accounted for the largest share, owing to the growing need for scalable, real-time, and multi-location traceability systems across pharmaceutical, food, medical device, and cosmetics supply chains. Cloud deployment allows manufacturers, contract manufacturers, logistics companies, distributors, and authorities to exchange data about serialization, aggregation, shipments, and compliance requirements through one centralized system. Moreover, it simplifies partner-to-partner communication significantly. This segment enjoys high traction since companies gradually switch from compliance-focused traceability systems at each production location to those covering entire enterprises and capable of functioning across multiple countries, packaging lines, and regulatory compliance. Additionally, cloud deployment does not entail any additional costs for keeping an IT system locally and ensures quicker adaptation in case regulations about serialization and reporting change. This factor plays a major role for pharmaceutical & biopharmaceutical companies that need compliance in different areas, including DSCSA, EU FMD, and others.
No comments: